NCT02114671View on ClinicalTrials.gov

A Study to Investigate the Phototoxic Potential of Faldaprevir

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Healthy
Interventions
DRUG

Faldaprevir high dose

capsules, oral

DRUG

Placebo

capsule, oral

DRUG

Ciprofloxacin

tablets, oral

DRUG

Faldaprevir low dose

capsules, oral

Trial Locations (1)

Unknown

1241.42.44001 Boehringer Ingelheim Investigational Site, Edinburgh

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02114671 - A Study to Investigate the Phototoxic Potential of Faldaprevir | Biotech Hunter | Biotech Hunter